Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator

Shun Kaneko,Shunsuke Imai,Tomomi Uchikubo-Kamo,Tamao Hisano,Nobuaki Asao,Mikako Shirouzu,Ichio Shimada

DOI: https://doi.org/10.1038/s41467-024-47792-6

IF: 16.6

2024-05-13

Nature Communications

Abstract:G-protein-coupled receptors (GPCRs) play pivotal roles in various physiological processes. These receptors are activated to different extents by diverse orthosteric ligands and allosteric modulators. However, the mechanisms underlying these variations in signaling activity by allosteric modulators remain largely elusive. Here, we determine the three-dimensional structure of the μ-opioid receptor (MOR), a class A GPCR, in complex with the G i protein and an allosteric modulator, BMS-986122, using cryogenic electron microscopy. Our results reveal that BMS-986122 binding induces changes in the map densities corresponding to R167 3.50 and Y254 5.58 , key residues in the structural motifs conserved among class A GPCRs. Nuclear magnetic resonance analyses of MOR in the absence of the G i protein reveal that BMS-986122 binding enhances the formation of the interaction between R167 3.50 and Y254 5.58 , thus stabilizing the fully-activated conformation, where the intracellular half of TM6 is outward-shifted to allow for interaction with the G i protein. These findings illuminate that allosteric modulators like BMS-986122 can potentiate receptor activation through alterations in the conformational dynamics in the core region of GPCRs. Together, our results demonstrate the regulatory mechanisms of GPCRs, providing insights into the rational development of therapeutics targeting GPCRs.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the activation mechanism of μ - opioid receptor (MOR) when it binds to the allosteric modulator BMS - 986122. Specifically, the researchers hope to reveal how BMS - 986122 enhances the activation degree of MOR by changing the conformational dynamics of the MOR core region through determining the three - dimensional structure of MOR in the state of binding to G protein and BMS - 986122. In addition, the study also aims to explore how the interaction between the two key residues, R1673.50 and Y2545.58, is affected by BMS - 986122, and the regulatory effect of this interaction on MOR function.

In the study, cryo - electron microscopy (cryo - EM) technology was used to analyze the structures of MOR under different conditions, and nuclear magnetic resonance (NMR) spectroscopy was combined to deeply understand the dynamic processes behind these structural changes. Through these methods, the researchers were able to observe the changes in the internal structure of MOR after binding to BMS - 986122, especially the enhanced interaction between R1673.50 and Y2545.58, which helps to stabilize the fully activated conformation of MOR, thereby increasing its activity.

Overall, this study not only enhances our understanding of the activation mechanism of MOR, but also provides important insights for the rational design of therapeutic drugs targeting GPCRs.